Clinical trial
Phase IV Study of the Use of Sequential DFP-DFO Versus DFP in Thalassemia Major Patients
NCT00733811 is registered in ClinicalTrials.gov with Azienda Ospedaliera V. Cervello as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IV Study of the Use of Sequential DFP-DFO Versus DFP in Thalassemia Major Patients
- Lead sponsor
- Azienda Ospedaliera V. Cervello
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2000
- Completion date
- January 31, 2008
- Enrollment
- 213 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
beta-thalassemia, thalassemia major